New eye drops aim to control wet AMD without needles
NCT ID NCT06704009
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 31 times
Summary
This early-phase study tested an eye drop called NT-101 in 20 people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The main goal was to check safety, and researchers also looked for signs that the drops might reduce fluid buildup and improve vision. The treatment is designed to control the disease, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WET AGE RELATED MACULAR DEGENERATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke Eye Center
Durham, North Carolina, 27705, United States
-
Elman Retina Group
Rosedale, Maryland, 21237, United States
-
Erie Retina Research
Erie, Pennsylvania, 16505, United States
-
Texas Retina Associates
Dallas, Texas, 75231, United States
Conditions
Explore the condition pages connected to this study.